FDA Inspection 1178398 — Lonza Bend Inc.

Lonza Bend Inc. — FEI 3003722743

The FDA completed an inspection of Lonza Bend Inc. on August 5, 2022 in Bend, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bend, OR (United States)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations